Genetic Technologies Limited

GENE · NASDAQ
Analyze with AI
6/30/2024
6/30/2023
6/30/2022
6/30/2021
Assets
Cash & Equivalents$1,021$7,851$11,731$20,902
Short-Term Investments$0$17$0$0
Receivables$2,127$192$2,421$1,074
Inventory$206$326$398$77
Other Curr. Assets$19$1,730$18$2
Total Curr. Assets$3,695$10,498$14,717$22,236
Property Plant & Equip (Net)$264$599$953$638
Goodwill$1,785$3,117$4,507$4,507
Intangibles$360$520$625$5,132
Long-Term Investments$0$4,115$0$0
Tax Assets$82$122$0$0
Other NC Assets$0-$4,237-$6,085-$9,540
Total NC Assets$2,491$4,237$6,085$736
Other Assets$0$122$0$0
Total Assets$6,187$14,856$20,802$22,972
Liabilities
Payables$1,458$838$1,154$270
Short-Term Debt$644$0$0$0
Tax Payable$0$0$0$0
Deferred Revenue$742$849$814$1
Other Curr. Liab.$572$779$969$491
Total Curr. Liab.$4,195$3,312$3,812$1,405
LT Debt$0$0$0$0
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$82$122$148$0
Other NC Liab.$56$30$22$9
Total NC Liab.$161$382$559$33
Other Liabilities$0$0$0$0
Cap. Leases$232$229$653$204
Total Liabilities$4,356$3,694$4,371$1,439
Equity
Pref Stock$0$0$0$0
Common Stock$163,818$161,343$155,139$153,575
Retained Earnings-$166,376-$156,716-$150,206-$143,075
AOCI$4,389$6,536$11,499$11,033
Other Equity$0$0$0$0
Total Equity$1,830$11,163$16,431$21,533
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$6,187$14,856$20,802$22,972
Net Debt-$377-$7,851-$11,731-$20,902